Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2022
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
Jill Lindley, BS
Research Scientist
JMI Laboratories
Disclosure(s): AbbVie: Grant/Research Support
Poster(s):
125 -
Induction of Resistance Against Antipseudomonal Agents: Comparison of Novel
b-Lactam/
b-Lactamase Inhibitor (BL/BLI) Combinations and Other
b-lactam Agents
Thursday, October 20, 2022
12:15 PM – 1:30 PM
US ET
1692 - Ceftibuten-Xeruborbactam: In vitro Potency against
Enterobacterales
in Comparison with Other Oral Beta-lactams (BL) and Beta-lactamase Inhibitor (BLI) Combinations
Saturday, October 22, 2022
12:15 PM – 1:30 PM
US ET
1693 - Meropenem-Xeruborbactam: In Vitro Potency against Gram-Negative Bacteria in Comparison with Marketed and Investigational Beta-lactam (BL)/Beta-lactamase Inhibitor (BLI) Combinations
Saturday, October 22, 2022
12:15 PM – 1:30 PM
US ET
.png)
.png)